For: | Lahtinen P, Jalanka J, Mattila E, Tillonen J, Bergman P, Satokari R, Arkkila P. Fecal microbiota transplantation for the maintenance of remission in patients with ulcerative colitis: A randomized controlled trial. World J Gastroenterol 2023; 29(17): 2666-2678 [PMID: 37213403 DOI: 10.3748/wjg.v29.i17.2666] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v29/i17/2666.htm |
Number | Citing Articles |
1 |
Lukas Bethlehem, Maria Manuela Estevinho, Ari Grinspan, Fernando Magro, Jeremiah J Faith, Jean-Frederic Colombel. Microbiota therapeutics for inflammatory bowel disease: the way forward. The Lancet Gastroenterology & Hepatology 2024; 9(5): 476 doi: 10.1016/S2468-1253(23)00441-7
|
2 |
Shi-Yan Zhang. Navigating new horizons in inflammatory bowel disease: Integrative approaches and innovations. World Journal of Gastroenterology 2024; 30(41): 4411-4416 doi: 10.3748/wjg.v30.i41.4411
|
3 |
Junyi Bai, Ying Wang, Fuhao Li, Yueyao Wu, Jun Chen, Meng Li, Xi Wang, Bin Lv. Research advancements and perspectives of inflammatory bowel disease: A comprehensive review. Science Progress 2024; 107(2) doi: 10.1177/00368504241253709
|
4 |
Jee Young Lee, Yehwon Kim, Jiyoun Kim, Jiyeun Kate Kim. Fecal Microbiota Transplantation: Indications, Methods, and Challenges. Journal of Microbiology 2024; 62(12): 1057 doi: 10.1007/s12275-024-00184-3
|
5 |
Xueyi Qian, Hua Jiang, Yao Wu, Huimin Shao, Weijie He, Yinmei He, Xin Bao, Lianjun He, Yuliang Jia, Zhenyu Xu. Fecal Microbiota Transplantation Combined with Prebiotics Ameliorates Ulcerative Colitis in Mice. Future Microbiology 2023; 18(17): 1251 doi: 10.2217/fmb-2023-0001
|
6 |
Andrea R. Merchak, MacKenzie L. Bolen, Malú Gámez Tansey, Kelly B. Menees. Thinking outside the brain: Gut microbiome influence on innate immunity within neurodegenerative disease. Neurotherapeutics 2024; 21(6): e00476 doi: 10.1016/j.neurot.2024.e00476
|
7 |
Connor Prosty, Khaled Katergi, Jesse Papenburg, Alexander Lawandi, Todd C Lee, Hao Shi, Philip Burnham, Lee Swem, Bertrand Routy, Cedric P Yansouni, Matthew P Cheng. Causal role of the gut microbiome in certain human diseases: a narrative review. eGastroenterology 2024; 2(3): e100086 doi: 10.1136/egastro-2024-100086
|
8 |
Rami Khalaf, Martina Sciberras, Pierre Ellul. The role of the fecal microbiota in inflammatory bowel disease. European Journal of Gastroenterology & Hepatology 2024; 36(11): 1249 doi: 10.1097/MEG.0000000000002818
|
9 |
Benjamin H Mullish, Blair Merrick, Mohammed Nabil Quraishi, Aggie Bak, Christopher A Green, David J Moore, Robert J Porter, Ngozi T Elumogo, Jonathan P Segal, Naveen Sharma, Belinda Marsh, Graziella Kontkowski, Susan E Manzoor, Ailsa L Hart, Christopher Settle, Josbert J Keller, Peter Hawkey, Tariq H Iqbal, Simon D Goldenberg, Horace R T Williams.
The use of faecal microbiota transplant as treatment for recurrent or refractory
Clostridioides difficile
infection and other potential indications: second edition of joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines
. Gut 2024; 73(7): 1 doi: 10.1136/gutjnl-2023-331550
|
10 |
Jonathan A. Montrose, Satya Kurada, Monika Fischer. Current and future microbiome-based therapies in inflammatory bowel disease. Current Opinion in Gastroenterology 2024; 40(4): 258 doi: 10.1097/MOG.0000000000001027
|
11 |
Umang Arora, Saurabh Kedia, Vineet Ahuja. The practice of fecal microbiota transplantation in inflammatory bowel disease. Intestinal Research 2024; 22(1): 44 doi: 10.5217/ir.2023.00085
|
12 |
B.H. Mullish, B. Merrick, M.N. Quraishi, A. Bak, C.A. Green, D.J. Moore, R.J. Porter, N.T. Elumogo, J.P. Segal, N. Sharma, B. Marsh, G. Kontkowski, S.E. Manzoor, A.L. Hart, C. Settle, J.J. Keller, P. Hawkey, T.H. Iqbal, S.D. Goldenberg, H.R.T. Williams. The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridioides difficile infection and other potential indications: second edition of joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines. Journal of Hospital Infection 2024; 148: 189 doi: 10.1016/j.jhin.2024.03.001
|
13 |
Walaa K. Mousa, Aya Al Ali. The Gut Microbiome Advances Precision Medicine and Diagnostics for Inflammatory Bowel Diseases. International Journal of Molecular Sciences 2024; 25(20): 11259 doi: 10.3390/ijms252011259
|
14 |
Malik Kasapoglu, Rajesh Yadavalli, Sarosh Nawaz, Abdulaziz Althwanay, Esraa M AlEdani, Harleen Kaur, Samia Butt. The Impact of Microbiome Interventions on the Progression and Severity of Inflammatory Bowel Disease: A Systematic Review. Cureus 2024; doi: 10.7759/cureus.60786
|
15 |
Yue Yin, Weibo Feng, Xilang Chen, Jie Chen, Guodong Wang, Limin Xia, Kaichun Wu. Intestinal microecology dysbiosis in inflammatory bowel disease: Pathogenesis and therapeutic strategies. The Innovation Medicine 2024; 2(4): 100092 doi: 10.59717/j.xinn-med.2024.100092
|
16 |
Tao Zhang, Xiaoang Li, Jun Li, Feng Sun, Liping Duan. Gut microbiome‐targeted therapies as adjuvant treatments in inflammatory bowel diseases: a systematic review and network meta‐analysis. Journal of Gastroenterology and Hepatology 2024; doi: 10.1111/jgh.16795
|